Cargando…
Cognitive Imapirment in Multiple Sclerosis: Relation to Dysability, Duration and Type of Disease
BACKGROUND: Cognitive dysfunctions are often presented as a symptom in multiple sclerosis which is associated with both structural and functional imapirments of neuronal networks in the brain. OBJECTIVE: The aim of the study was to evaluate the influence of dysability, duration and type of disesase...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AVICENA, d.o.o., Sarajevo
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10122534/ https://www.ncbi.nlm.nih.gov/pubmed/37095882 http://dx.doi.org/10.5455/msm.2023.35.23-27 |
_version_ | 1785029510805061632 |
---|---|
author | Sabanagic-Hajric, Selma Memic-Serdarevic, Amra Sulejmanpasic, Gorana Salihovic-Besirovic, Dzenita Kurtovic, Avdo Bajramagic, Nermina Mehmedika-Suljic, Enra |
author_facet | Sabanagic-Hajric, Selma Memic-Serdarevic, Amra Sulejmanpasic, Gorana Salihovic-Besirovic, Dzenita Kurtovic, Avdo Bajramagic, Nermina Mehmedika-Suljic, Enra |
author_sort | Sabanagic-Hajric, Selma |
collection | PubMed |
description | BACKGROUND: Cognitive dysfunctions are often presented as a symptom in multiple sclerosis which is associated with both structural and functional imapirments of neuronal networks in the brain. OBJECTIVE: The aim of the study was to evaluate the influence of dysability, duration and type of disesase on cognitive functions in multiple sclerosis patients. METHODS: This study included 60 MS patients treated at the Department of Neurology, Clinical Center University of Sarajevo. Inclusion criteria were clinically definite diagnosis of multiple sclerosis, 18 years of age or older and were able to give written informed consent. Cognitive function was evaluated by the Montreal Cognitive Assessment (MoCa) screening test. Mann-Whitney and Kruskal-Wallis test were used for comparisons between clinical characteristics and MoCa test scores. RESULTS: Out of 63.33% of patients had EDSS <=4.5. Disease lasted longer than 10 years in 30% of patients. 80% had relapsing-remitting MS and 20% had secondary progressive MS. 84,2 % of patients with EDSS ≤ 4.5 had cognitive dysfunction. Higher disability (rho=0,306, p<0,05), progressive type of disease (rho=0,377, p< 0,01) and longer disease duration (rho=0,282, p<0,05) were associated with worse overall cognitive functions. Level of disability showed statistical significant correlation with the executive functions and language domains of cognition (p<0.01). Longer disease duration was significant correlated with executive functions (p<0,01) and language domains (p<0,01), while progressive type of disease was signifacant correlated only with executive functions domain (p<0,01). MoCa score variables did not show a statistically significant difference in relation to the number of relapses per year and the use of imunoterapy. Statistically significant negative correlation was obtained between executive functions domain and level of disability, disease duration and progressive type of disease, while language domain significantly correlated only with disability level and progressive type of disease. CONCLUSION: High percentage of MS patients has cognitive impairment. Patients with higher disability were presented with lower cognitive abilities, especially in executive functions and language domains. Higher frequency of cognitive impairment were presented in progessive forms of disaese and longer disease duration with strong influence on executive functions domains of cognition. |
format | Online Article Text |
id | pubmed-10122534 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | AVICENA, d.o.o., Sarajevo |
record_format | MEDLINE/PubMed |
spelling | pubmed-101225342023-04-23 Cognitive Imapirment in Multiple Sclerosis: Relation to Dysability, Duration and Type of Disease Sabanagic-Hajric, Selma Memic-Serdarevic, Amra Sulejmanpasic, Gorana Salihovic-Besirovic, Dzenita Kurtovic, Avdo Bajramagic, Nermina Mehmedika-Suljic, Enra Mater Sociomed Original Paper BACKGROUND: Cognitive dysfunctions are often presented as a symptom in multiple sclerosis which is associated with both structural and functional imapirments of neuronal networks in the brain. OBJECTIVE: The aim of the study was to evaluate the influence of dysability, duration and type of disesase on cognitive functions in multiple sclerosis patients. METHODS: This study included 60 MS patients treated at the Department of Neurology, Clinical Center University of Sarajevo. Inclusion criteria were clinically definite diagnosis of multiple sclerosis, 18 years of age or older and were able to give written informed consent. Cognitive function was evaluated by the Montreal Cognitive Assessment (MoCa) screening test. Mann-Whitney and Kruskal-Wallis test were used for comparisons between clinical characteristics and MoCa test scores. RESULTS: Out of 63.33% of patients had EDSS <=4.5. Disease lasted longer than 10 years in 30% of patients. 80% had relapsing-remitting MS and 20% had secondary progressive MS. 84,2 % of patients with EDSS ≤ 4.5 had cognitive dysfunction. Higher disability (rho=0,306, p<0,05), progressive type of disease (rho=0,377, p< 0,01) and longer disease duration (rho=0,282, p<0,05) were associated with worse overall cognitive functions. Level of disability showed statistical significant correlation with the executive functions and language domains of cognition (p<0.01). Longer disease duration was significant correlated with executive functions (p<0,01) and language domains (p<0,01), while progressive type of disease was signifacant correlated only with executive functions domain (p<0,01). MoCa score variables did not show a statistically significant difference in relation to the number of relapses per year and the use of imunoterapy. Statistically significant negative correlation was obtained between executive functions domain and level of disability, disease duration and progressive type of disease, while language domain significantly correlated only with disability level and progressive type of disease. CONCLUSION: High percentage of MS patients has cognitive impairment. Patients with higher disability were presented with lower cognitive abilities, especially in executive functions and language domains. Higher frequency of cognitive impairment were presented in progessive forms of disaese and longer disease duration with strong influence on executive functions domains of cognition. AVICENA, d.o.o., Sarajevo 2023-03 /pmc/articles/PMC10122534/ /pubmed/37095882 http://dx.doi.org/10.5455/msm.2023.35.23-27 Text en © 2023 Selma Sabanagic-Hajric, Amra Memic-Serdarevic, Gorana Sulejmanpasic, Dzenita Salihovic-Besirovic, Avdo Kurtovic, Nermina Bajramagic, Enra Mehmedika-Suljic https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Paper Sabanagic-Hajric, Selma Memic-Serdarevic, Amra Sulejmanpasic, Gorana Salihovic-Besirovic, Dzenita Kurtovic, Avdo Bajramagic, Nermina Mehmedika-Suljic, Enra Cognitive Imapirment in Multiple Sclerosis: Relation to Dysability, Duration and Type of Disease |
title | Cognitive Imapirment in Multiple Sclerosis: Relation to Dysability, Duration and Type of Disease |
title_full | Cognitive Imapirment in Multiple Sclerosis: Relation to Dysability, Duration and Type of Disease |
title_fullStr | Cognitive Imapirment in Multiple Sclerosis: Relation to Dysability, Duration and Type of Disease |
title_full_unstemmed | Cognitive Imapirment in Multiple Sclerosis: Relation to Dysability, Duration and Type of Disease |
title_short | Cognitive Imapirment in Multiple Sclerosis: Relation to Dysability, Duration and Type of Disease |
title_sort | cognitive imapirment in multiple sclerosis: relation to dysability, duration and type of disease |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10122534/ https://www.ncbi.nlm.nih.gov/pubmed/37095882 http://dx.doi.org/10.5455/msm.2023.35.23-27 |
work_keys_str_mv | AT sabanagichajricselma cognitiveimapirmentinmultiplesclerosisrelationtodysabilitydurationandtypeofdisease AT memicserdarevicamra cognitiveimapirmentinmultiplesclerosisrelationtodysabilitydurationandtypeofdisease AT sulejmanpasicgorana cognitiveimapirmentinmultiplesclerosisrelationtodysabilitydurationandtypeofdisease AT salihovicbesirovicdzenita cognitiveimapirmentinmultiplesclerosisrelationtodysabilitydurationandtypeofdisease AT kurtovicavdo cognitiveimapirmentinmultiplesclerosisrelationtodysabilitydurationandtypeofdisease AT bajramagicnermina cognitiveimapirmentinmultiplesclerosisrelationtodysabilitydurationandtypeofdisease AT mehmedikasuljicenra cognitiveimapirmentinmultiplesclerosisrelationtodysabilitydurationandtypeofdisease |